Purchase Order 75D30120P08860

The Centers for Disease Control and Prevention Pittsburgh awarded a cost-reimbursable definitive contract to Vitalant Research Institute to characterize seroprevalence of SARS-CoV-2 antibodies in the US population on May 12, 2020, with a ceiling value of $46.4 million and an ultimate completion date of May 11, 2024. The originating solicitation, issued as a special notice in December 2021, contemplated a sole-source modification under FAR 6.302-1, citing Vitalant's 18 months of prior...

The Food and Drug Administration awarded a purchase order to Vitalant (Vitalant Research Institute division) valued at $4.77 million on September 30, 2019, for the HIV Risk Questionnaire Study, an assessment of the predictive value of a panel of questions for recent infection with human immunodeficiency virus. Work is performed in Scottsdale, Arizona. The contract carries firm fixed-price terms and no set-aside designation. Ultimate completion date is September 29, 2023. The originating...

The Centers for Disease Control and Prevention awarded a $2.8 million firm fixed price contract to Laboratory Corporation of America, operating as Labcorp, to provide residual blood specimen collection and SARS-CoV-2 serology testing services under the Multistate Assessment of SARS-CoV-2 Seroprevalence study. Labcorp will collect approximately 33,800 residual sera samples per month from all 50 states, Washington D.C. and Puerto Rico, distributed by age, and test for SARS-CoV-2 nucleocapsid...

This purchase order from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awards $537,000 to San Diego Blood Bank for plasma collection services from 35 vaccinated subjects per authorized vaccine panel. Per the solicitation, the vendor must identify, test, and draw plasma via plasmapheresis from adults who have received either the Moderna, Pfizer, Janssen, or up to three additional vaccines authorized for emergency use under an EUA....

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Creative Testing Solutions, a non-profit organization based in Tempe, Arizona. The $4,332,565.36 contract is for blood donor testing services at two Army medical facilities in Texas and Missouri. The contract has an ultimate completion date of September 30, 2025 and does not utilize a small business set-aside. The contract is a follow-on to a previous award held by Creative Testing Solutions, and the services...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Fenway Community Health Center, Inc., a non-profit organization, for $149,365.00 to provide biological specimens from HIV-positive men who are under or initiating integrase inhibitor-based antiretroviral therapy. The purpose is to develop and assess retroviral integrase, as integrase strand transfer inhibitor (INSTI)-based regimens are increasing in use and...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order to Boca Biolistics, LLC, a for-profit limited liability company, for the provision of POSITIVE HIV PLASMA. The contract has a potential value of $149,775.00 and a completion date of July 15, 2019. Boca Biolistics is a trusted partner for the development of in vitro diagnostic and biopharmaceutical products, and has received prior awards from federal agencies such as...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $75,680 firm fixed price purchase order to Premier Medical USA Corporation of Plainfield, NJ for the delivery of SURESTATUS HIV-1 RECENCY CARD TEST AND FIRST RESPONSE HIV 1-2.O CARD TEST (VERSION 2.0). The tests will help the CDC monitor and track HIV infection rates as part of its efforts to prevent and treat HIV/AIDS. No set-aside designation was used for this award. Premier Medical...

Vitalant Research Institute has been awarded a delivery order against the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute's Recipient Epidemiology and Donor Evaluation Study III (REDS-III) International Sites contract vehicle. This $716,542 cost-no-fee contract will support the REDS-III Phase 3 effort in Brazil. As the prime contractor, Vitalant VRI will leverage its expertise in blood donation and transfusion research to provide...

This purchase order, awarded November 25, 2009, provides funding for hepatitis laboratory testing services to be performed by Vitalant Research Institute (Vitalant VRI), the research and specialized services division of Vitalant, the nation's largest independent blood services provider. The contract covers the period from December 1, 2009, through February 28, 2010, with a ceiling value of $63,000 and is structured as a firm fixed-price purchase order. The work will be performed in Bethesda,...